The purpose of this work is to show the importance of the testicular artery and the deleterious effects of its injury from a literature review. There were 75 papers relating the testicular vascularization during the period from 1949 to 2017, coming from base electronic data. The corresponding articles concerned retrospective and prospective studies, review articles published in journals with editorial board, reading and science committee. These articles were written in French and English. The results show the success rate of the Fowler-Stephens orchidopexy was varied. The testicular artery maintains testicular thermoregulation, has an endocrine and nutrition roles, besides it was the artery of fertility. The intratesticular anastomoses weren't seen between the testicular, cremasteric and differential arteries to rats, human and other mammalians. The testicular artery is the only artery that irrigates the testicular parenchyma. However, studies have observed extratesticular communications between the testicular, deferential and cremasteric arteries. In conclusion, the testicular artery is the main artery providing blood supply to the testicle. This artery plays an important role from a physiological point of view. Its lesions have important consequences on the functional and structural future of the testicle. This invites the strict respect of this artery during surgery spermatic cord or its environment.

Chromosomal abnormalities have a variable severity, which can range from lethality before birth to the need for permanent medical care. The objective of this work was to propose a strategy to the struggle against chromosomal abnormalities through Departments of cytogenetics from literature review. Several documents have been consulted on the activities of Departments (or Services) of cytogenetics in relation to health care, ethical, legal and social problems concerning chromosomal abnormalities. In addition there are teaching and international collaboration in the field of cytogenetics. The corresponding articles have been published in journals with editorial, reading and scientific committees. According to this literature review, Services of cytogenetics should emphasize appropriate technologies and affordable prices, which can reach a significant portion of the population. In these Services, genetic counseling respects the right to full information and possible solutions regarding chromosomal abnormalities. Prevention through community sensitization, screening of populations and the possibility of early diagnosis should be carried out. The teaching of cytogenetics is therefore the starting point from which programs to combat chromosomal abnormalities will be introduced. Departments of cytogenetics must be supported by regulatory structures constituted by the scientific, medical and non-professional communities. Research is an important component of medical cytogenetics as well as international collaboration. This work includes a set of coordinated actions whose implementation would deal with chromosomal abnormalities.

Diabetes is a real public health problem in the world. In Africa in general and in Côte d'Ivoire in particular, the management of diabetes is complicated by socio-economic difficulties. After the diagnosis of diabetes, its typing is carried out on the basis of clinical criteria. With the discovery of many subgroups of diabetes especially in Africa, the classification of diabetes is made difficult. This difficulty may raise questions about the adequacy of the therapeutic treatment of patients. The purpose of this study was to study mainly the contribution of basal C-peptidemia in the typing of diabetic subjects. The material concerned a population of 220 diabetics who carried out their peptide C assay and monitored at the Yopougon-ABIDJAN University and Hospital Center. Basal C-Peptidemia was assayed by competitive radio-immunoassay using the kit CIS -BIO Shering. The results revealed that the classification based on clinical signs was improved after the C-peptide assay. Indeed, after C-peptidemia, type 1 diabetics with low C-peptidemia (<0.5 ng/ml) and type 2 diabetics with normal Cpeptidemia (0.5 ng/ml to 3 ng/ml). In conclusion, the determination of peptide C appears as an undeniable tool for better classification of diabetic patients. The results of C-peptidemia would direct the practitioner towards a more adequate treatment in the patients studied.